AAAAAA

   
Results: 1-17 |
Results: 17
Prospective randomized controlled multicenter trial on steroids plus ramipril in proteinuric IgA nephropathy
Authors: Manno, C Gesualdo, L D'Altri, C Rossini, M Grandaliano, G Schena, FP
Citation: C. Manno et al., Prospective randomized controlled multicenter trial on steroids plus ramipril in proteinuric IgA nephropathy, J NEPHROL, 14(4), 2001, pp. 248-252
Electrical activity of the diaphragm during pressure support ventilation in acute respiratory failure
Authors: Beck, J Gottfried, SB Navalesi, P Skrobik, Y Comtois, N Rossini, M Sinderby, C
Citation: J. Beck et al., Electrical activity of the diaphragm during pressure support ventilation in acute respiratory failure, AM J R CRIT, 164(3), 2001, pp. 419-424
Thymic hyperplasia and lung carcinomas in a line of mice transgenic for keratin 5-driven HPV16 E6/E7 oncogenes
Authors: Carraresi, L Tripodi, SA Mulder, LCF Bertini, S Nuti, S Schuerfeld, K Cintorino, M Bensi, G Rossini, M Mora, M
Citation: L. Carraresi et al., Thymic hyperplasia and lung carcinomas in a line of mice transgenic for keratin 5-driven HPV16 E6/E7 oncogenes, ONCOGENE, 20(56), 2001, pp. 8148-8153
Radial bending breaking resistance derived by densitometric evaluation predicts femoral neck fracture
Authors: Gatti, D Sartori, E Braga, V Corallo, F Rossini, M Adami, S
Citation: D. Gatti et al., Radial bending breaking resistance derived by densitometric evaluation predicts femoral neck fracture, OSTEOPOR IN, 12(10), 2001, pp. 864-869
Effects of oral alendronate in elderly patients with osteoporosis and mildprimary hyperparathyroidism
Authors: Rossini, M Gatti, D Isaia, G Sartori, L Braga, V Adami, S
Citation: M. Rossini et al., Effects of oral alendronate in elderly patients with osteoporosis and mildprimary hyperparathyroidism, J BONE MIN, 16(1), 2001, pp. 113-119
Effects of two intermittent alendronate regimens in the prevention or treatment of postmenopausal osteoporosis
Authors: Rossini, M Gatti, D Girardello, S Braga, V James, G Adami, S
Citation: M. Rossini et al., Effects of two intermittent alendronate regimens in the prevention or treatment of postmenopausal osteoporosis, BONE, 27(1), 2000, pp. 119-122
HIV-1 diversity in Brazil: Genetic, biologic, and immunologic characterization of HIV-1 strains in three potential HIV vaccine evaluation sites
Authors: Bongertz, V Bou-Habib, DC Brigido, LFM Caseiro, M Chequer, PJN Couto-Fernandez, JC Ferreira, PC Galvao-Castro, B Greco, D Guimaraes, ML de Carvalho, MIL Morgado, MG Oliveira, CAF Osmanov, S Ramos, CA Rossini, M Sabino, E Tanuri, A Ueda, M
Citation: V. Bongertz et al., HIV-1 diversity in Brazil: Genetic, biologic, and immunologic characterization of HIV-1 strains in three potential HIV vaccine evaluation sites, J ACQ IMM D, 23(2), 2000, pp. 184-193
An in vivo model of hyperacute rejection: characterization and evaluation of the effect of transgenic human complement inhibitors
Authors: Mora, M Lazzeri, M Marsicano, G Mulder, LCF Carraresi, L Pieri, A Benanchi, A Grifoni, D Nuti, S Bruzzone, P Comporti, M Cortesini, R Rossini, M
Citation: M. Mora et al., An in vivo model of hyperacute rejection: characterization and evaluation of the effect of transgenic human complement inhibitors, TRANSGEN RE, 9(3), 2000, pp. 205-213
Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4
Authors: Morini, M Astigiano, S Mora, M Ricotta, C Ferrari, N Mantero, S Levi, G Rossini, M Barbieri, O
Citation: M. Morini et al., Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4, ONCOGENE, 19(52), 2000, pp. 6007-6014
Tunable supramolecular synthons and versatile, water-soluble building blocks for crystal engineering: [(eta(5)-C5H4COOH)(2)Co-III](+) and its zwitterionic form [(eta(5)-C5H4COOH) (eta(5)-C5H4COO)Co-III]
Authors: Braga, D Maini, L Polito, M Rossini, M Grepioni, F
Citation: D. Braga et al., Tunable supramolecular synthons and versatile, water-soluble building blocks for crystal engineering: [(eta(5)-C5H4COOH)(2)Co-III](+) and its zwitterionic form [(eta(5)-C5H4COOH) (eta(5)-C5H4COO)Co-III], CHEM-EUR J, 6(22), 2000, pp. 4227-4235
Approximating surfaces with discontinuities
Authors: Bozzini, M Rossini, M
Citation: M. Bozzini et M. Rossini, Approximating surfaces with discontinuities, MATH COMP M, 31(6-7), 2000, pp. 193-213
Association of CTR and COLIA1 alleles with BMD values in peri- and postmenopausal women
Authors: Braga, V Mottes, M Mirandola, S Lisi, V Malerba, G Sartori, L Bianchi, G Gatti, D Rossini, M Bianchini, D Adami, S
Citation: V. Braga et al., Association of CTR and COLIA1 alleles with BMD values in peri- and postmenopausal women, CALCIF TIS, 67(5), 2000, pp. 361-366
Intramuscular clodronate therapy in postmenopausal osteoporosis
Authors: Rossini, M Braga, V Gatti, D Gerardi, D Zamberlan, N Adami, S
Citation: M. Rossini et al., Intramuscular clodronate therapy in postmenopausal osteoporosis, BONE, 24(2), 1999, pp. 125-129
Site-specific effects of strength training on bone structure and geometry of ultradistal radius in postmenopausal women
Authors: Adami, S Gatti, D Braga, V Bianchini, D Rossini, M
Citation: S. Adami et al., Site-specific effects of strength training on bone structure and geometry of ultradistal radius in postmenopausal women, J BONE MIN, 14(1), 1999, pp. 120-124
Optimization of the coagulation-flocculation treatment: Influence of rapidmix parameters
Authors: Rossini, M Garrido, JG Galluzzo, M
Citation: M. Rossini et al., Optimization of the coagulation-flocculation treatment: Influence of rapidmix parameters, WATER RES, 33(8), 1999, pp. 1817-1826
Spironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist
Authors: Moghetti, P Castello, R Zamberlan, N Rossini, M Gatti, D Negri, C Tosi, F Muggeo, M Adami, S
Citation: P. Moghetti et al., Spironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist, J CLIN END, 84(4), 1999, pp. 1250-1254
Authors' response: Spironolactone but not flutamide administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist
Authors: Moghetti, P Castello, R Zamberlan, N Rossini, M Gatti, D Negri, C Tosi, F Muggeo, M Adami, S
Citation: P. Moghetti et al., Authors' response: Spironolactone but not flutamide administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist, J CLIN END, 84(12), 1999, pp. 4747-4747
Risultati: 1-17 |